Terug
Dagbereik
€ 13,48
€ 14,13
52-Weeksbereik
€ 10,28
€ 28,40
Volume
1.133.413
50D / 200D Gem.
€ 13,81
/
€ 18,38
Vorige Slotkoers
€ 13,51
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -64,1 | 0,4 |
| P/B | 3,6 | 2,9 |
| ROE % | -8,7 | 3,8 |
| Net Margin % | -4,9 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Generating 16,93M in free cash flow
PEG of 0,97 suggests growth is underpriced
Capital efficient — spends only 0,51% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)53,24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-8,68%
ROIC-3,91%
Net Margin-4,91%
Op. Margin-4,60%
Veiligheid
Debt / Equity
0,00
Current Ratio3,60
Interest Coverage-4,72
Waardering
P/E Ratio
-64,10
P/B Ratio3,57
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 53,24% | Revenue Growth (3Y) | 45,58% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 260,21M | Net Income (TTM) | -12,78M |
| ROE | -8,68% | ROA | -4,18% |
| Gross Margin | 65,52% | Operating Margin | -4,60% |
| Net Margin | -4,91% | Free Cash Flow (TTM) | 16,93M |
| ROIC | -3,91% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 3,60 |
| Interest Coverage | -4,72 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -64,10 | P/B Ratio | 3,57 |
| P/S Ratio | 3,15 | PEG Ratio | 0,97 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 819,06M | Enterprise Value | 597,03M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 260,21M | 169,80M | 122,78M | 89,19M |
| Net Income | -12,78M | -47,14M | -67,51M | -72,52M |
| EPS (Diluted) | -0,22 | -0,85 | -1,21 | -1,30 |
| Gross Profit | 170,50M | 102,88M | 69,97M | 42,79M |
| Operating Income | -11,97M | -43,65M | -66,00M | -72,35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 305,41M | 150,89M | 175,08M | 221,80M |
| Total Liabilities | 75,73M | 86,26M | 76,16M | 66,19M |
| Shareholders' Equity | 229,68M | 64,63M | 98,92M | 155,61M |
| Total Debt | 0,0 | 30,19M | 30,58M | 30,81M |
| Cash & Equivalents | 222,04M | 76,39M | 115,64M | 168,12M |
| Current Assets | 272,93M | 113,06M | 142,88M | 188,56M |
| Current Liabilities | 75,73M | 53,95M | 43,79M | 34,51M |